Description
The coronary stents industry is a highly competitive one in which innovation occurs rapidly and the technology landscape evolves at a fast pace. As the global population is aging and has a longer life expectancy, the prevalence of coronary heart disease and co-morbid conditions such as hypertension, diabetes and obesity is projected to rise and stimulate the demand for coronary stents. Additionally, a growing acceptance of drug-eluting stents as a more effective treatment for coronary heart disease, along with increasing awareness about coronary stents among patients, is expected to boost procedural volumes. New technologies, such as bioresorbable scaffolds, and bifurcation and biodegradable polymers stents, are projected to enter major markets in the next years and increase the utilization of stents in interventional cardiology.
Despite the challenging environment, opportunities still exist in the global market for coronary stents, as there is still a high need for non-invasive therapies with enhanced safety and efficacy, and there are various niches of the market, such as bifurcation and complex lesions, that require more extensive treatment options. Additionally, the new bioresorbable stents have the potential to eliminate the negative issues of durable polymer stents, and are therefore expected to induce a significant shift in the treatment of coronary heart disease, encouraging also more patients to undergo stent implantation surgery.
This Report, The World Market for Stents (Drug Eluting and Bare Metal Product Markets in U.S., E.U., Japan, China, India and ROW), authored by medical device analyst Adriana Rusu, provides a complete overview of cardiovascular disease, the role of stents in treatment, the success of bare metal and drug-eluting products, as well as market sizes and forecasts to 2017. Included in this reports coverage:
- Market Size and Forecast -Cardiovascular Disease Statistics (Mortality, Morbidity, Cost by Country)
- Regional Breakout of Bare Metal and Drug-Eluting Stent Markets (U.S., E.U., Japan, China, India, ROW)
- Categorization of Drug-Eluting Stents by Polymer, Drug, Platform
- Coronary Stents Using Biodegradable Polymers, Novel Coating and Direct Drug Application
- Assessment of Bioresorbable Stents
- Dedicated Bifurcation, Dedicated Small Vessel Stent Products
- Major Competitors Market Share
- Significant Trends in Market and Near and Long-Term Impact
- Recent Mergers and Acquisitions
- Key Company Profiles
The major markets of US, Europe, and Japan experienced significant challenges in recent years, including price declines, decreasing volumes of percutaneous coronary interventions, and lower penetration rates for drug-eluting stents resulted from cost constraints and reductions in healthcare budgets. Additionally, the intensified competition among manufacturers also contributed to the decline in average stent selling prices in these regions. Despite that, the market potential for coronary stents in these regions remains quite attractive, given the aging population and high longevity. However, the decreasing reimbursement rates and the intensifying competition for market share are expected to continue to lead to price declines and hamper significantly the market growth.
As part of its coverage of the stents industry, the following companies are profiled:
- Abbott Laboratories
- Biosensors International
- Boston Scientific
- Biotronik SE & Co.KG
- CID Vascular
- Elixir Medical Corporation
- Medtronic
- Meril Life Sciences Pvt. Ltd.
- MicroPort Medical (Shanghai) Co., Ltd Minvasys
- OrbusNeich
- REVA Medical
- Stentys S.A.
- Terumo Corporation
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, science, medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with key industry officials, consultants, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical, biotechnology and contract research organizations included marketing directors, division managers, and product representatives.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
Disease Overview
Cardiovascular Disease
Market Overview
Revenue Forecast
CHAPTER TWO: CARDIOVASCULAR DISEASE OVERVIEW
Disease Overview
Top Ten Causes of Death
World Cardiovascular Disease Statistics
Mortality Rates for IHD
Economic Burden of Cardiovascular Disease
Expenditure on Cardiovascular Disease, Worldwide
Prevalence of Ischemic Heart Disease
CHAPTER THREE: CORONARY STENTS OVERVIEW
Overview
Restenosis
Types of Stents
Bare Metal Stents
First Generation of Bare Metal Stents
Second Generation of Bare Metal Stents
Third Generation of Bare Metal Stents
Omega Platinum-Chromium Stent
Nuloy Molybdenum-Rhenium Stent
Safety Issues of Bare Metal Stents
Drug-Eluting Stents
Types of Drugs Used on Drug-Eluting Stents
Paclitaxel
Sirolimus
Everolimus
Tacrolimus
Biolimus A9
Novolimus
Other Drug Classes
Types of Polymers
Safety Concerns of Drug-Eluting Stents
Late Stent Thrombosis
Mechanical Problems of Polymers
CHAPTER FOUR: RECENT ADVANCES IN CORONARY STENTS TECHNOLOGIES
Reduced Polymer Coatings
Biodegradable Polymers
Advantages and Disadvantages of Biodegradable Polymers
Current Biodegradable Polymers Stents
BioMatrix
Nobori
Supralimus
Infinnium
DESyne BD stent
Synergy
MiStent
BioMime
Abrax
Polymer-Free and Novel Coatings Drug-eluting Stents
Optima Jet
Cre8
Orsiro Hybrid DES
EPC Capturing Technology
Direct Application of Drug on Stent Surface
Amazonia Pax
Yukon DES
BioFreedom
Mitsu
Medtronic S10 platform
Catania stent
MGuard Prime
Titan-2
Bioresorbable Stents
Drawbacks of Bioresorbable Polymeric Stents
Selected Bioresorbable Coronary Stents
The Absorb stent
Biotronik’s Dreams stent
DESolve stent
ReZolve Stent
IDEAL stent
Other bioresorbable stents
Lesion Specific Stents
Dedicated Bifurcated Stents
Axxess
Nile Pax
Stentys Self-Apposing stent
Taxus Petal
Xience Side Branch Access
Sparrow
Taxus Liberte Atom
Xience nano
CHAPTER FIVE: INDUSTRY STRUCTURE & TRENDS
Sales and Marketing Capabilities
Differentiation Strategies
Improved Stent Materials
Reduced DAPT Duration
Lesion-Specific Stents
Extended Indications
Significant Trends In The Coronary Stents Market
Market Drivers
New devices Expanded Indications
Acute Myocardial Infarction and Diabetes
Emerging Markets Are Expected To Spur The Overall Market Growth.
Market Restraints
Price decline hampers growth in the overall market.
Cost Constraints
Difficult Economic Conditions
Notable Recent Industry Events
Recent Mergers and Acquisitions
Biosensors International acquired CardioMind and Devax
Medtronic Acquired Invatec
Xenogenics Corporation Acquired Bioabsorbable Therapeutics
Market Exits
CHAPTER SIX: MARKET REVENUES AND FORECAST
Market by Type of Stent
Drug Eluting Stents Market
Market Snapshot
Products Analysis
Xience V
Promus Element/Plus
Resolute Integrity
Market Dynamics in the Drug-Eluting Stents Segment
Revenue Forecast
Bare Metal Stents Market
Market Snapshot
Market Dynamics
Revenue Forecast
United States
Market Snapshot
Revenue Forecast
Europe
Market snapshot
Revenue Forecast
Japan
Market snapshot
Revenue forecast
China
Market Snapshot
Revenue forecast
India
Market snapshot
Revenue Forecast
Rest of the World
Revenue Forecast
CHAPTER SEVEN: COMPANY PROFILES
Abbott Laboratories
Biosensors International
Boston Scientific
Biotronik SE & Co.KG
CID Vascular
Elixir Medical Corporation
Medtronic
Meril Life Sciences Pvt. Ltd.
MicroPort Medical (Shanghai) Co., Ltd
Minvasys
OrbusNeich
REVA Medical
Stentys S.A.
Terumo Corporation
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
Table 1-1: Top Ten Causes of Death in the World by Development Level, 2008
Figure 1-1: Global Market Revenues Forecast 2010-2017
(Bare Metal Stents, Drug Eluding Stents, Total)
CHAPTER TWO: CARDIOVASCULAR DISEASE OVERVIEW
Table 2-1: Top Ten Causes of Death in the World by Geographical Region, 2008
Table 2-2: Top Ten Causes of Death in the World by Development Level, 2008
Table 2-3: Top Ten Causes of Death in the World in High Income Countries, 2008
Table 2-4: Top Ten Causes of Death in the World in Middle Income Countries, 2008
Table 2-5: Top Ten Causes of Death in the World in Low Income Countries, 2008
Figure 2-1: Percentage of Deaths Related to Cardiovascular Disease in
the Seven Major World Markets, 2008
Table 2-6: Projected Deaths from Ischemic Heart Disease (IHD) and Acute
Myocardial Infarction (AMI) in the Seven Major World Markets, 2012
Table 2-7: Age-Standardized Mortality Rates for Ischemic Heart Disease (IHD)
and Acute Myocardial Infarction (AMI) by Gender in the Seven Major
World Markets, 2009
Table 2-8: Estimated Total Cost of Cardiovascular Disease in Europe, 2006
Table 2-9: Estimated Total Cost of Cardiovascular Disease in Major Markets, 2012
CHAPTER THREE: CORONARY STENTS OVERVIEW
Table 3-1: Selected Marketed Bare Metal Stents, 2012
Table 3-2: Selected Bare Metal Coronary Stents, 2012
Table 3-3: Selected Marketed Drug-Eluting Stents, 2012
Table 3-4: Selected Features of Different Generations of Commercially
Available Drug-eluting Stents
CHAPTER FOUR: RECENT ADVANCES IN CORONARY STENTS
TECHNOLOGIES
Table 4-1: Selected Coronary Stents using Biodegradable Polymers, 2012
Table 4-2: Selected Coronary Polymer-free and Novel Coating Stents, 2012
Table 4-3: Selected Direct Drug Application Coronary Stents, 2012
Table 4-4: Selected Coronary Polymer and Drug-free Coating Stents, 2012
Table 4-5: Advantages and Disadvantages of Bioresorbable Stents
Table 4-6: Selected Bioresorbable Coronary Stents, 2012
Table 4-7: Selected Dedicated Bifurcation Coronary Drug-Eluting Stents, 2012
Table 4-8: Selected Dedicated Small Vessels Coronary Drug-Eluting Stents, 2012
Table 4-9: Drug Release Parameters of Selected Drug-Eluting Stents
CHAPTER FIVE: INDUSTRY STRUCTURE
Table 5-1: Industry Structure – Major Competitors and Selected
Marketed Products, 2012
Table 5-2: Significant Trends in the Coronary Stents Market, 2012
CHAPTER SIX: MARKET REVENUES AND FORECAST
Table 6-1: Coronary Stents Estimated Global Market Shares, 2011
Figure 6-1: Stents Market Share, 2011
Table 6-2: Global Market Revenues for Coronary Stents ($ Millions)
Figure 6-2: Global Stents Market Forecast
Figure 6-3: Market Breakdown by Type of Stent (BMS, DES)
Figure 6-4: Drug Eluting Stents Market Shre, 2011
Table 6-3: Global Market Revenues for Coronary Stents ($ Millions)
Figure 6-5: Global Market Revenues Forecast ($ Billions)Drug-Eluting Stents, 2010-2017
Figure 6-6: Market Breakdown by Type of Stent (BMS, DES)
Figure 6-7: Market Share Bare Metal Stents
Table 6-4: Global Market Revenues for Coronary Bare Metal Stents, 2010-2017 (Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-8: Bare Metal Stents Market 2010-2017
Figure 6-9: United States Share of World Market
Table 6-5: U.S. Market Revenues for Coronary Stents (Bare Metal Stent, Drug Eluding Stent,Total)
Figure 6-10: U.S. Market Revenues for Coronary Stents(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-11: Europe Share of World Stents Market
Table 6-6: European Market Revenues for Coronary Stents(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-12: European Market Revenues for Coronary Stents(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-13: Japan Share of World Stents Market
Table 6-7: Japanese Market Revenues for Coronary Stents(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-14: Japanese Market Revenues for Coronary Stents(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-15: China Share of World Stents Market
Table 6-8: Market Revenues for Coronary Stents in China(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-15: Market Revenues for Coronary Stents in China(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-16: India Share of World Market
Table 6-9: Market Revenues for Coronary Stents in India(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-17: Market Revenues for Coronary Stents in India(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-18: Rest of World Share of World Stents Market
Table 6-10: Market Revenues for Coronary Stents in the Rest of the World(Bare Metal Stent, Drug Eluding Stent, Total)
Figure 6-19: Market Revenues for Coronary Stents in the Rest of the World(Bare Metal Stent, Drug Eluding Stent, Total)
